Evaluating the Benefits of New Drugs in Health Technology Assessment Using Multiple Criteria Decision Analysis: A Case Study on Metastatic Prostate Cancer With the Dental and Pharmaceuticals Benefits Agency (TLV) in Sweden

Background. Multiple criteria decision analysis (MCDA) has been identified as a prospective methodology for assisting decision makers in evaluating the benefits of new medicines in health technology assessment (HTA); however, limited empirical evidence exists from real-world applications. Objective....

Descripción completa

Detalles Bibliográficos
Autor principal: Angelis, Aris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855406/
https://www.ncbi.nlm.nih.gov/pubmed/35187241
http://dx.doi.org/10.1177/2381468318796218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855406/
https://www.ncbi.nlm.nih.gov/pubmed/35187241
http://dx.doi.org/10.1177/2381468318796218

Ejemplares similares